Interpace Biosciences Inc. (IDXG)

[humboldt111502]

IDXG mean analyst target: $3.00 according to newburghpress.com

http://newburghpress.com/2016/09/19/stock-under-consideration-interpace-diagnostics-group-inc-nasdaqidxg-dht-holdings-inc-nysedht/

Interpace Diagnostics Group, Inc. (NASDAQ:IDXG)

Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) opened its last trading session at $0.16 and closed at $0.16 representing a Upside of 11.28 Percent. The stock currently shows the Market Capitalization of 3.31 Million. The company touched its 52-Week High on Sep 21, 2015 which was $2.05 and 52-Week Low on Sep 16, 2016 as $0.16. The company reported its last earnings on Aug 16 BMO and will report its next earnings on Nov 10 – Nov 14 (Est.).

1 Year Target estimate of Interpace Diagnostics Group, Inc. is $3. The stock’s Dividend stands at 0 and Dividend Yield stands at 0 Percent. The stock is currently trading at Distance from 20-Day Simple Moving Average of -25.87% while its Distance from 50-Day Simple Moving Average is -38.24 Percent. Interpace Diagnostics Group, Inc. represents Distance from 200-Day simple Moving Average as -47.07 Percent.

According to the Last Earnings Report, Interpace Diagnostics Group, Inc. reported Actual EPS of $-0.25/Share whereas, the Analyst Estimated EPS was $-0.4/share. The difference between Actual EPS and Estimated EPS was $0.15/share. This represented an Earnings Surprise of 37.5%.

1 number of analysts provided their estimates on Interpace Diagnostics Group, Inc., where the Average Price Target for the stock is $3. They also projected Low Price Target as $3 while High Price Target is set at $3.